StocktoriaBioNexus Gene Lab Corp BGLC
Nasdaq · XNAS · stock · Services-Medical Laboratories
Chart by TradingView
3/9
Piotroski F — financial health
13.26
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $7.4M | $9.5M | $9.8M | $10.9M | $13.4M |
| Gross profit | $1.1M | $1.3M | $1.3M | $1.3M | $2.3M |
| Operating income | -$3.0M | -$1.6M | -$2.6M | -$291,177 | $1.1M |
| Net income | -$3.0M | -$1.6M | -$2.6M | -$355,966 | $751,571 |
| Operating cash flow | -$1.8M | -$2.1M | -$1.8M | $551,822 | $9,161 |
| Free cash flow | -$1.9M | -$2.3M | -$2.0M | $551,822 | $5,999 |
| Total assets | $9.3M | $10.4M | $11.4M | $8.7M | $9.6M |
| Total liabilities | $637,856 | $2.1M | $1.7M | $2.1M | $2.4M |
| Shareholders' equity | $8.6M | $8.3M | $9.7M | $6.7M | $7.2M |
| Ratios | |||||
| Gross margin | 14.6% | 13.6% | 13.6% | 11.5% | 17.0% |
| Operating margin | -39.9% | -16.5% | -26.5% | -2.7% | 7.9% |
| Net margin | -40.2% | -16.8% | -26.9% | -3.3% | 5.6% |
| FCF margin | -25.3% | -24.4% | -20.2% | 5.0% | 0.0% |
| Return on assets | -32.3% | -15.3% | -23.1% | -4.1% | 7.8% |
| Return on equity | -34.6% | -19.2% | -27.2% | -5.3% | 10.5% |
| Current ratio | 10.46 | 3.81 | 4.93 | 3.00 | 3.07 |
| Revenue growth | -21.9% | -2.7% | -10.6% | -18.2% | 17.3% |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 13.26 (safe)
- Working capital / assets 0.533
- Retained earnings / assets -0.695
- EBIT / assets -0.32
- Equity / liabilities 13.506
Sector peers
GOOG · MSFT · META · BABA · DIS · HCA · all Services →
Source: SEC EDGAR filings · CIK 0001737523 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.